News
Ofatumumab receives accelerated approval from FDA
The drug was approved under the FDA’s accelerated approval process, which allows drugs that meet unmet medical needs to be approved faster.
News
Ticagrelor tops clopidogrel in recent study
Ticagrelor significantly reduced the rate of death from vascular causes, myocardial infarction, or stroke without an increase in major bleeding....
News
Survival improves for AYAs with leukemia and lymphoma
However, their survival still lags behind survival in children.
News
Potential cause of R-CHOP failure ruled out
Researchers say they have come one step closer to determining the cause of R-CHOP failure in diffuse large B-cell lymphoma (DLBCL) by ruling out a...
News
Study shows imatinib response is durable and improves with time
SAN FRANCISCO—The longest duration study of imatinib treatment for patients with Ph+ CML shows 86% of patients are still alive 7 years after...
News
Newly identified NHP2 biallelic mutation can cause dyskeratosis congenita
Copenhagen— Researchers have identified a new biallelic mutation in the telomerase component NHP2, which can cause the premature aging syndrome...
News
Study shows drug is safe and effective in cardiac patients
Bivalirudin was associated with a lower rate of major bleeding and death from cardiac and other causes at 30 days from treatment initiation.
News
Researchers elucidate mechanism of heparin contaminant
In March, a team led by Ram Sasisekharan, PhD, of Massachusetts Institute of Technology in Cambridge, identified the contaminant responsible for...